Acute Ischemic Stroke Pipeline Highlights - 2017 - Research and Markets

DUBLIN--(BUSINESS WIRE)--

Research and Markets has announced the addition of the "Acute Ischemic Stroke Pipeline Highlights - 2017" drug pipelines to their offering.

This report, Acute Ischemic Stroke Pipeline Highlights - 2017, provides most up-to-date information on key pipeline products in the global Acute Ischemic Stroke market. It covers emerging therapies for Acute Ischemic Stroke in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Acute Ischemic Stroke pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Acute Ischemic Stroke pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Acute Ischemic Stroke pipeline products by the company.

Short-term Launch Highlights:

Find out which Acute Ischemic Stroke pipeline products will be launched in the US and Ex-US till 2020.

Summary:

• Acute Ischemic Stroke phase 3 clinical trial pipeline products
• Acute Ischemic Stroke phase 2 clinical trial pipeline products
• Acute Ischemic Stroke phase 1 clinical trial pipeline products
• Acute Ischemic Stroke preclinical research pipeline products
• Acute Ischemic Stroke discovery stage pipeline products
• Acute Ischemic Stroke pipeline products short-term launch highlights
  

Key Topics Covered:

1. Acute Ischemic Stroke Pipeline by Stages

2. Acute Ischemic Stroke Pipeline by Drug Class

3. Acute Ischemic Stroke Pipeline by Company

4. Acute Ischemic Stroke Phase 3 Clinical Trial Insights

5. Acute Ischemic Stroke Phase 2 Clinical Trial Insights

6. Acute Ischemic Stroke Phase 1 Clinical Trial Insights

7. Acute Ischemic Stroke Preclinical Research Insights

8. Acute Ischemic Stroke Discovery Stage Insights

9. Appendix

10. Research Methodology

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/qfj8cj/acute_ischemic

View source version on businesswire.com: http://www.businesswire.com/news/home/20170120005146/en/